Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

The Lancet Oncology
Alessandro GronchiPaolo Giovanni Casali

Abstract

Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in localised high-risk soft-tissue sarcoma of the extremities or trunk wall, and no difference in overall survival benefit between three cycles versus five cycles of the same neoadjuvant regimen. We aimed to show the superiority of the neoadjuvant administration of histotype-tailored regimen to standard chemotherapy. For this international, open-label, randomised, controlled, phase 3, multicentre trial, patients were enrolled from 32 hospitals in Italy, Spain, France, and Poland. Eligible patients were aged 18 years or older with localised, high-risk (high malignancy grade, 5 cm or longer in diameter, and deeply located according to the investing fascia), soft-tissue sarcoma of the extremities or trunk wall and belonging to one of five histological subtypes: high-grade myxoid liposarcoma, leiomyosarcoma, synovial sarcoma, malignant peripheral nerve sheath tumour, and undifferentiated pleomorphic sarcoma. Patients were randomly assigned (1:1) to receive three cycles of full-dose standard chemotherapy (epirubicin 60 mg/m2 per day [short infusion, days 1 and 2] plus ifosfamide 3 g/m2 per day [days ...Continue Reading

Citations

Jun 28, 2017·Journal of Magnetic Resonance Imaging : JMRI·Valentina D A CorinoLuca T Mainardi
Mar 29, 2018·World Journal of Surgical Oncology·Hiroshi UrakawaYoshihiro Nishida
May 17, 2018·Future Oncology·Jean-Yves Blay
May 17, 2018·Future Oncology·Isabelle Ray-CoquardSebastian Bauer
Feb 17, 2018·JAMA Oncology·Rolf D IsselsUNKNOWN European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society f
Jun 8, 2018·JAMA Oncology·Suzanne George, Andrew J Wagner
Jun 28, 2018·Journal of Surgical Oncology·Gannon L CurtisNathan W Mesko
Feb 25, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·R CorreaJ A Medina
Oct 10, 2018·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Sebastian ZschaeckPirus Ghadjar
Dec 5, 2018·Expert Opinion on Investigational Drugs·Juan Martin-LiberalXavier García Del Muro
Dec 21, 2018·Journal of Magnetic Resonance Imaging : JMRI·Amandine CrombéOlivier Saut
Oct 27, 2018·Current Treatment Options in Oncology·Sarah Abaricia, Angela C Hirbe
Nov 6, 2018·Genes, Chromosomes & Cancer·Frederic ChibonSophie Le Guellec
Feb 2, 2018·Annals of Surgical Oncology·Eric LuChristopher W Ryan
Mar 9, 2019·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·J Jakob, J Schmolders
Mar 8, 2019·Expert Opinion on Emerging Drugs·Giacomo G BaldiAndrea Ferrari
Aug 9, 2017·Nature Reviews. Clinical Oncology·Robin L Jones, Khin Thway
May 11, 2019·Journal of Oncology Practice·Damon R ReedOdion Binitie
Mar 26, 2019·Nuclear Medicine Communications·Andrea SambriCostantino Errani
Jan 19, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·T AssiC Honoré
Jan 13, 2018·Current Opinion in Otolaryngology & Head and Neck Surgery·Alberto PadernoCesare Piazza
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia Stacchiotti, Brian Andrew Van Tine
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex Thomas John LeeRobin Lewis Jones
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rick L HaasAxel Le Cesne
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brigitte C Widemann, Antoine Italiano
Dec 21, 2019·Expert Review of Anticancer Therapy·Candace L Haddox, Richard F Riedel
Jan 23, 2020·Cancers·Kenji Nakano, Shunji Takahashi
Mar 4, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·D ViñalA Redondo
Jan 15, 2020·Journal of Cancer Research and Clinical Oncology·Monika ScheerUNKNOWN Cooperative Weichteilsarkom Studiengruppe [CWS]
May 19, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandro GronchiPaolo Giovanni Casali
Jul 29, 2020·Annals of Surgical Oncology·Christina L RolandAlessandro Gronchi
Jul 9, 2020·International Journal of Cancer. Journal International Du Cancer·Yoshihiro NishidaAkira Kawai
Sep 7, 2019·Journal of Medical Case Reports·Chieko MiyazakiNaohiro Sata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.